Linked Life Data

21617235

Source:http://linkedlifedata.com/resource/pubmed/id/21617235

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-5-27
pubmed:abstractText
Pemetrexed (Alimta™) is used frequently for the treatment of lung cancer and is associated with various types and grades of cutaneous side-effects. We report here one patient who presented with asymptomatic hyperpigmentation of the skin, localized on the palms of the hands and the soles of the feet after administration of pemetrexed for lung cancer despite receiving standard pre-medication. This type of skin toxicity was completely reversible after withdrawal of the drug (without pharmacologic intervention) and has to our knowledge not been reported before.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1791-7530
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1753-5
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Pemetrexed-induced hyperpigmentation of the skin.
pubmed:affiliation
Department of Medical Oncology, Oncologisch Centrum, UZ Brussels, Belgium. Denis.schallier@uzbrussel.be
pubmed:publicationType
Journal Article, Case Reports